Eli Lilly has a lot of innovation that goes beyond obesity drugs: analyst

Lilly has new, innovative drugs in the works such as a non-opiod pain drug, but there is a lot of discussion around supply for Eli Lilly, says Evan Seigerman, managing director of biopharma equity research at BMO Capital Markets. Subscribe to BNN Bloomberg to watch more videos: https://www.youtube.com/BNNBloomberg Connect with BNN Bloomberg: For the latest news visit: https://www.bnnbloomberg.ca For a full video offering visit BNN Bloomberg: https://www.bnnbloomberg.ca/video BNN Bloomberg on Facebook: https://www.facebook.com/BNNBloomberg BNN Bloomberg on Twitter: https://twitter.com/bnnbloomberg BNN Bloomberg on Instagram: https://www.instagram.com/bnnbloomberg BNN Bloomberg on LinkedIn: https://www.linkedin.com/company/bnn-bloomberg -- BNN Bloomberg is Canada’s only TV service devoted exclusively to business, finance and the markets.